Molecular profiling of DNMT3A and ASXL1 in chronic myeloid leukemia and their association with response to treatment with tyrosine kinase inhibitors
World Academy of Sciences Journal · 24.06.2026 · 8 (4) · 1-11
DOI: 10.3892/wasj.2026.487 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Academy of Sciences Journal, online erschienen am 24.06.2026. Verfasst von Amna Alneaemy und 2 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alneaemy, A., Al‑rikabi, A., & Alwan, A. (2026). Molecular profiling of DNMT3A and ASXL1 in chronic myeloid leukemia and their association with response to treatment with tyrosine kinase inhibitors. World Academy of Sciences Journal, 8(4), 1-11. https://doi.org/10.3892/wasj.2026.487
Vancouver
Alneaemy A, Al‑rikabi A, Alwan A. Molecular profiling of DNMT3A and ASXL1 in chronic myeloid leukemia and their association with response to treatment with tyrosine kinase inhibitors. World Academy of Sciences Journal. 2026;8(4):1-11. doi:10.3892/wasj.2026.487
BibTeX
@article{Alneaemy2026,
author = {Alneaemy, Amna and Al‑rikabi, Abdulameer and Alwan, Alaa},
title = {Molecular profiling of DNMT3A and ASXL1 in chronic myeloid leukemia and their association with response to treatment with tyrosine kinase inhibitors},
journal = {World Academy of Sciences Journal},
year = {2026},
volume = {8},
number = {4},
pages = {1--11},
doi = {10.3892/wasj.2026.487}
}
EUVIMED